Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Go back to Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
(NYSE: CLDI) Delayed: 1.04 --0 (-0%)
Previous Close $1.04    52 Week High $ 
Open $1.04    52 Week Low $ 
Day High $1.04    P/E N/A 
Day Low $1.04    EPS $ 
Volume 110